Home›Companies›Biotech & Pharma›Metanoia Bio

Metanoia Bio Inc

Develops potential treatments for people with type 2 diabetes.

Updated Nov 10, 2026·Latest SEC filing Mar 18, 2026·Suggest an edit

About Metanoia Bio

Metanoia Bio is a private company based in Lewes, Delaware. It has reported $900,000 raised in one offering on Form D since March 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 2, 2026Mar 18, 2026$900,000of $5.0M target5$180KDebt, OptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Metanoia Bio's Form D filed Mar 18, 2026.

ST
Slavica Tudzarova
Scientific Cofounder
AW
Abraham Van Wyk
Cofounder and director
Abraham Van Wyk appears on 2 Form D filings at 2 companies:
  • GRI Bio, director: Apr 17, 2015
  • Metanoia Bio, cofounder and director: Mar 18, 2026
OG
Oppel Greeff
Cofounder and director

Sources

  1. SECMetanoia Bio Inc filing history
  2. ResearchSBIR company and award profile